Kyle Carver

Principal Accounting Officer, Kadmon Holdings, Inc.

Companies

Evommune, Inc.Chief financial officer Nov 5, 2025 to now¹
Kadmon Holdings, Inc.Principal Accounting Officer Oct 29, 2018 to Nov 9, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Evommune, Inc. EVMN60,335 shares³$311.9K at $5.17Jul 8, 2026
Kadmon Holdings, Inc.0 shares⁴Nov 9, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 8, 2026Bought 1,000 shares at $13.26 of Evommune, Inc.³
May 28, 2026Sold 18,175 shares at $22.84 of Evommune, Inc.⁵
May 28, 2026Exercised options 15,000 shares at $2.99 of Evommune, Inc.⁵
Dec 9, 2025Shares withheld for tax 13,290 shares at $17.84 of Evommune, Inc.⁶
Nov 7, 2025Converted 3,175 shares of Evommune, Inc.⁷
Nov 9, 2021Returned to company 15,420 shares at $9.50 of Kadmon Holdings, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREvommune, Inc., Chief financial officer
2
SEC EDGARKadmon Holdings, Inc., Principal Accounting Officer
3
SEC EDGAREvommune, Inc. shares after the filing of Jul 8, 2026
4
SEC EDGARKadmon Holdings, Inc. shares after the filing of Nov 9, 2021
5
SEC EDGARForm 4 filed Jun 1, 2026
6
SEC EDGARForm 4 filed Dec 11, 2025
7
SEC EDGARForm 4 filed Nov 12, 2025